Mochi Health vs Hims & Hers
All-in cost at every dose, fee structure, care model, pharmacy disclosure and terms — compared on one basis.
Only Mochi Health publishes a price we could capture ($3,336 for a first year at a maintenance dose). The other does not, so this comparison cannot be settled on cost.
What can be compared is what each discloses: visit model, pharmacy identity, laboratory requirement and cancellation terms. Those are below.
All-in monthly cost = medication + any recurring fee, at a named dose, before tax and before prepaid discounts. Captured 2026-08-05. How we verify a price.
Mochi Health vs Hims & Hers at every dose
A single headline figure assumes a maintenance dose neither you nor your prescriber has chosen yet. This is the same comparison at all six strengths.
Hims & Hers has left the compounded tirzepatide market. It now carries brand-name products only, with membership billed separately from medication. A price comparison against Mochi Health therefore compares two different products under two different regulatory regimes, not two prices for the same thing.
Mochi Health still sells a compounded preparation at $278 a month all-in at a 10 mg maintenance dose, about $3,336 for a first year. That is not FDA-approved and is not reviewed by FDA before marketing. The brand route is reviewed and costs more. Which is right for you turns on coverage, not on the headline numbers.
Any comparison you find that still ranks Hims & Hers for compounded tirzepatide is working from a stale capture. Check the verification date on it.
Mochi Health against Hims & Hers at every dose
| Dose | Mochi Health | Hims & Hers | Cheaper |
|---|---|---|---|
| 2.5 mg | $278 | — | — |
| 5 mg | $278 | — | — |
| 7.5 mg | $278 | — | — |
| 10 mg | $278 | — | — |
| 12.5 mg | $278 | — | — |
| 15 mg | $278 | — | — |
What differs beyond price
Price is the easiest thing to compare and rarely the thing that decides satisfaction. These are the attributes each programme publishes.
| Attribute | Mochi Health | Hims & Hers |
|---|---|---|
| Pricing model | flat at every dose | model unknown |
| Membership | $79/mo | none |
| Prepaid rate | none published | none published |
| Visit model | video | async |
| Labs | optional | optional |
| Pharmacy disclosure | owned facility | brand only since Mar 2026 |
| Cancellation | membership recurring | membership recurring |
| Regulatory status | compounded, not FDA-approved | compounded, not FDA-approved |
| Evidence status | ✓ verified at source | no price published |
Which one, for whom
If you want the lowest total cost: neither can be ranked on cost until both publish a price.
If you want budget certainty: Mochi Health, which holds one price at every strength.
If you want to verify the supply chain: neither names a dispensing pharmacy in a way we could verify — ask both directly.
If you may need to stop early: compare the cancellation rows above before prepaying. Compounded medication is generally not refundable once it has shipped, so a multi-month term is the wrong structure during titration, when intolerance is the most likely reason to stop.
Switching between them
Usually possible after a clinical review, and the two real risks are a supply gap while a new intake is processed and a new prescriber restarting titration rather than continuing your dose. Confirm dose continuity in writing before cancelling anything, because a month back at 2.5 mg is a month of lost progress no price difference recovers.
Fee structure, side by side
Mochi Health charges a mandatory membership of $79 a month on top of medication. Hims & Hers charges no recurring fee.
This is where most published comparisons break. A table quoting medication alone understates a membership programme by the full fee, every month, for as long as you stay. Every figure here folds it in, which is why our number can be higher than the one on a programme's own homepage.
Care model and what it buys
Mochi Health: video, labs optional, dietitian access. Hims & Hers: async, labs optional, included.
Video visits, included laboratory work and real clinician access cost money to provide, and programmes providing them are rarely cheapest. That is what you are paying for. The failure is paying a premium for an asynchronous questionnaire a cheaper programme provides identically.
Verification, which outranks both
Mochi Health: owned facility. Hims & Hers: brand only since Mar 2026.
A programme that will not name the pharmacy compounding your medicine is asking you to inject an unidentified preparation weekly. State boards publish licensee registers and FDA publishes outsourcing-facility registrations and warning letters, all free and searchable — but only if you have a name. That question outranks a price difference of almost any size.
Why this comparison cannot be settled on price
Only Mochi Health publishes a price we could capture, at about $3,336 for a first year at a maintenance dose. The other does not. A comparison that filled that gap with an estimate would be inventing the only number that matters.
What can be compared is what each discloses before you pay, and that is frequently the more useful comparison anyway. A programme that names its pharmacy, states its cancellation terms and publishes a price at every dose has told you how it will behave when something goes wrong.
What to do instead
Ask both for the total at 10 mg including every fee, in writing, and compare the replies against the programmes that already publish. If one answers in a sentence and the other does not answer at all, you have your comparison.
Why we publish the page anyway
Because the absence is the finding. Someone searching for this pairing deserves to know that one side cannot be priced, rather than being shown a fabricated number or no page at all.
Fee structure, side by side
Mochi Health charges a mandatory membership of $79 a month on top of medication. Hims & Hers charges no recurring fee.
This is where most published comparisons break. A table quoting medication alone understates a membership programme by the full fee, every month, for as long as you stay. Every figure here folds it in, which is why our number can be higher than the one on a programme's own homepage.
Care model and what it buys
Mochi Health: video, labs optional, dietitian access. Hims & Hers: async, labs optional, included.
Video visits, included laboratory work and real clinician access cost money to provide, and programmes providing them are rarely cheapest. That is what you are paying for. The failure is paying a premium for an asynchronous questionnaire a cheaper programme provides identically.
Verification, which outranks both
Mochi Health: owned facility. Hims & Hers: brand only since Mar 2026.
A programme that will not name the pharmacy compounding your medicine is asking you to inject an unidentified preparation weekly. State boards publish licensee registers and FDA publishes outsourcing-facility registrations and warning letters, all free and searchable — but only if you have a name. That question outranks a price difference of almost any size.
Open these rather than taking our word for it. Every one is a regulator, a trial registry, a label, an accreditor or the manufacturer.
Compare every programme on one screen
The matrix carries all-in price at every dose, fee structure, commitment terms, pharmacy disclosure and verification status for every programme we track.
Common questions
Is Mochi Health or Hims & Hers cheaper?
Only one of the two publishes a price we could capture, so this comparison cannot be settled on cost. Both are compared on terms and disclosure instead.
Do Mochi Health and Hims & Hers charge a membership on top of medication?
Mochi Health: yes, $79 a month. Hims & Hers: no. Every figure on this page includes it where charged.
Does Mochi Health or Hims & Hers name its dispensing pharmacy?
Mochi Health: owned facility. Hims & Hers: brand only since Mar 2026. It is the disclosure that lets you check a state board register before you inject anything weekly.
Can I switch between them mid-treatment?
Usually yes, after a clinical review. Confirm dose continuity in writing and do not cancel the old programme until the new one has shipped, because a supply gap costs more than a price difference.
Is either Mochi Health or Hims & Hers FDA-approved?
Compounded preparations are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality before marketing. Where a programme supplies brand product, that product is approved; the programme around it is not a regulated entity in the same sense.